These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 9763047

  • 21. Misoprostol versus oxytocin in the third stage of labor.
    Kundodyiwa TW, Majoko F, Rusakaniko S.
    Int J Gynaecol Obstet; 2001 Dec; 75(3):235-41. PubMed ID: 11728483
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Misoprostol in addition to routine treatment of postpartum hemorrhage: a hospital-based randomized-controlled trial in Karachi, Pakistan.
    Zuberi NF, Durocher J, Sikander R, Baber N, Blum J, Walraven G.
    BMC Pregnancy Childbirth; 2008 Aug 21; 8():40. PubMed ID: 18718007
    [Abstract] [Full Text] [Related]

  • 24. Administration of 400 μg of misoprostol to augment routine active management of the third stage of labor.
    Hofmeyr GJ, Fawole B, Mugerwa K, Godi NP, Blignaut Q, Mangesi L, Singata M, Brady L, Blum J.
    Int J Gynaecol Obstet; 2011 Feb 21; 112(2):98-102. PubMed ID: 21130990
    [Abstract] [Full Text] [Related]

  • 25. A double-blind, randomized, placebo-controlled trial of misoprostol and routine uterotonics for the prevention of postpartum hemorrhage.
    Fawole AO, Sotiloye OS, Hunyinbo KI, Umezulike AC, Okunlola MA, Adekanle DA, Osamor J, Adeyanju O, Olowookere OO, Adekunle AO, Singata M, Mangesi L, Hofmeyr GJ.
    Int J Gynaecol Obstet; 2011 Feb 21; 112(2):107-11. PubMed ID: 21130446
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. A randomized trial of sublingual misoprostol to augment routine third-stage management among women at risk of postpartum hemorrhage.
    Chaudhuri P, Majumdar A.
    Int J Gynaecol Obstet; 2016 Feb 21; 132(2):191-5. PubMed ID: 26613819
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial.
    Winikoff B, Dabash R, Durocher J, Darwish E, Nguyen TN, León W, Raghavan S, Medhat I, Huynh TK, Barrera G, Blum J.
    Lancet; 2010 Jan 16; 375(9710):210-6. PubMed ID: 20060161
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Sublingual misoprostol versus intravenous oxytocin in prevention of post-partum hemorrhage.
    Tewatia R, Rani S, Srivastav U, Makhija B.
    Arch Gynecol Obstet; 2014 Apr 16; 289(4):739-42. PubMed ID: 24045979
    [Abstract] [Full Text] [Related]

  • 38. A double-blind randomized controlled trial of oral misoprostol and intramuscular syntometrine in the management of the third stage of labor.
    Ng PS, Lai CY, Sahota DS, Yuen PM.
    Gynecol Obstet Invest; 2007 Apr 16; 63(1):55-60. PubMed ID: 16940738
    [Abstract] [Full Text] [Related]

  • 39. Oral misoprostol in the third stage of labor.
    Zachariah ES, Naidu M, Seshadri L.
    Int J Gynaecol Obstet; 2006 Jan 16; 92(1):23-6. PubMed ID: 16271721
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.